Effect Analysis of Carrilizumab Combined with Chemotherapy in the Treatment of Elderly Patients with NSCLC
Objective:To explore the efficacy of combination therapy with Carolizumab and chemotherapy in the treatment of elderly non-small cell lung cancer(NSCLC)patients.Methods:96 elderly NSCLC pa-tients in our hospital were randomly divided into a control group(n =48 cases)and an experimental group(n =48 cases)using a random number table method.The control group patients received chemotherapy treatment,while the experimental group patients received chemotherapy and treatment with Carolizumab.Compare the clin-ical efficacy,serum related indicator levels,and adverse reactions between two groups of patients.Results:Af-ter treatment,the clinical treatment efficiency of the experimental group was higher than that of the control group(P＜0.05),and the levels of VEGF,MMP-9,and CY211 were lower than those of the control group(P＜0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups of patients(P＞0.05).Conclusion:Karelizumab combined with chemotherapy has a significant thera-peutic effect and high drug safety in the treatment of elderly NSCLC,which is worthy of clinical promotion.
NETL
NSTL
万方数据
维普
